| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2022 | TNDM Tandem Diabetes Care Inc | Robertson Rebecca B76 | Director | Sell | 1,500 | $96.73 | $145,090.35 | -60.8% | -33.2% | -60.5% | |
| May 2, 2022 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 30,000 | $35.87 | $1,076,235.00 | -9.3% | -46.6% | -47.3% | |
| May 2, 2022 | Fry John J83 | General Counsel &Secretary | Sell | 429 | $22.36 | $9,594.55 | -0.5% | -35.0% | -47.5% | ||
| May 2, 2022 | RVP Retractable Technologies Inc | Leonard Braden Michael60 | 10% Owner | Buy | 430,000 | $3.73 | $1,603,219.16 | +4.7% | +19.7% | -58.2% | |
| May 2, 2022 | CVRX Cvrx, Inc. | Nielsen Kirk G.82 | Director | Buy | 42,088 | $5.97 | $251,269.56 | +1.3% | +42.3% | +107.6% | |
| May 2, 2022 | LAB Standard Biotools Inc. | Caligan Partners LP58 | 10% Owner | Buy | 400,000 | $2.69 | $1,075,574.00 | +1.5% | -47.2% | -48.2% | |
| Apr 29, 2022 | EW Edwards Lifesciences Corp | Mussallem Michael A65 | Chairman &CEO | Sell | 32,550 | $107.80 | $3,508,848.86 | -5.6% | +1.4% | -16.8% | |
| Apr 29, 2022 | STSS Sharps Technology Inc. | Blackman Alan R. | CIO And COO | Buy | 20,000 | $1.28 | $25,600.00 | +1.3% | -19.8% | -29.8% | |
| Apr 29, 2022 | TELA Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P.57 | See Footnote 2 | Buy | 15,000 | $9.10 | $136,550.00 | +0.1% | -12.2% | +1.5% | |
| Apr 28, 2022 | EW Edwards Lifesciences Corp | Marsh Martha H.46 | Director | Sell | 28,722 | $108.09 | $3,104,563.85 | -51.8% | -3.8% | -19.9% | |
| Apr 28, 2022 | ANGO Angiodynamics Inc | Helsel Dave71 | SVP Global Operations And R&D | Sell | 3,513 | $22.44 | $78,831.72 | -13.3% | +0.6% | -63.0% | |
| Apr 28, 2022 | EKSO Ekso Bionics Holdings, Inc. | Sherman Steven72 | CEO &Chairman | Sell | 6,862 | $2.41 | $16,520.95 | -1.1% | -28.5% | -37.7% | |
| Apr 27, 2022 | STSS Sharps Technology Inc. | Hayes Robert Michael | Chief Executive Officer | Buy | 4,000 | $1.50 | $6,000.00 | +17.4% | -34.4% | -41.4% | |
| Apr 27, 2022 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | President And CEO | Sell | 11,329 | $4.29 | $48,549.30 | -6.2% | -15.8% | -48.0% | |
| Apr 27, 2022 | IRMD Iradimed Corp | Susi Roger E.53 | President, CEO And Chairman | Sell | 10,000 | $40.50 | $404,996.00 | -1.6% | -6.7% | +0.4% | |
| Apr 27, 2022 | STSS Sharps Technology Inc. | Blackman Alan R. | CIO And COO | Buy | 10,000 | $1.25 | $12,500.00 | +1.4% | -34.4% | -41.4% | |
| Apr 26, 2022 | ISRG Intuitive Surgical Inc | Desantis Robert49 | EVP &Chief Product Officer | Sell | 1,611 | $253.04 | $407,647.44 | -6.0% | -10.4% | +20.6% | |
| Apr 26, 2022 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 2,725 | $2.17 | $5,913.25 | -3.2% | -6.7% | +46.6% | |
| Apr 26, 2022 | ISRG Intuitive Surgical Inc | Curet Myriam56 | EVP &Chief Medical Officer | Sell | 6,000 | $252.51 | $1,515,058.20 | -94.3% | -10.4% | +20.6% | |
| Apr 26, 2022 | TELA Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P.57 | See Footnote 2 | Buy | 15,000 | $9.32 | $139,850.00 | +0.2% | -10.0% | +5.4% | |
| Apr 26, 2022 | STIM Neuronetics, Inc. | Cannell Capital LLC69 | 10% Owner | Buy | 10,806 | $2.74 | $29,562.81 | +0.1% | +34.3% | -15.8% | |
| Apr 25, 2022 | STSS Sharps Technology Inc. | Blackman Alan R. | CIO And COO | Buy | 5,000 | $1.37 | $6,850.00 | +0.7% | -30.8% | -30.1% | |
| Apr 25, 2022 | DXCM Dexcom Inc | Pacelli Steven Robert57 | Managing Dir., Dexcom Ventures | Sell | 250 | $439.94 | $109,985.00 | -0.7% | -25.3% | +12.1% | |
| Apr 25, 2022 | BJDX Bluejay Diagnostics, Inc. | Fisher Kenneth R | Chief Financial Officer | Buy | 20,000 | $0.99 | $19,800.00 | New | +19.6% | -69.5% | |
| Apr 22, 2022 | STSS Sharps Technology Inc. | Blackman Alan R. | CIO And COO | Buy | 5,000 | $1.52 | $7,600.00 | +0.7% | -32.8% | -21.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.